IN2012DN04868A - - Google Patents

Download PDF

Info

Publication number
IN2012DN04868A
IN2012DN04868A IN4868DEN2012A IN2012DN04868A IN 2012DN04868 A IN2012DN04868 A IN 2012DN04868A IN 4868DEN2012 A IN4868DEN2012 A IN 4868DEN2012A IN 2012DN04868 A IN2012DN04868 A IN 2012DN04868A
Authority
IN
India
Prior art keywords
compounds
compound
formula
methods
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Wei-Guo Su
Weihan Zhang
Hong Jia
Yumin Cui
Yongxin Ren
Yang Sai
Zhenping Wu
Wenji Li
Jiangyong Shao
Zhenping Tian
Original Assignee
Hutchison Medipharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44029398&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN04868(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hutchison Medipharma Ltd filed Critical Hutchison Medipharma Ltd
Publication of IN2012DN04868A publication Critical patent/IN2012DN04868A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
IN4868DEN2012 2009-11-23 2010-11-23 IN2012DN04868A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2009101992592A CN102070618B (zh) 2009-11-23 2009-11-23 一种化合物及其晶体
PCT/CN2010/078997 WO2011060746A1 (fr) 2009-11-23 2010-11-23 Composé, certaines nouvelles formes de celui-ci, compositions pharmaceutiques de celui-ci et procédés de préparation et d'utilisation

Publications (1)

Publication Number Publication Date
IN2012DN04868A true IN2012DN04868A (fr) 2015-09-25

Family

ID=44029398

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4868DEN2012 IN2012DN04868A (fr) 2009-11-23 2010-11-23

Country Status (18)

Country Link
US (2) US8658658B2 (fr)
EP (1) EP2504331B1 (fr)
JP (1) JP5758399B2 (fr)
KR (1) KR101513784B1 (fr)
CN (2) CN102070618B (fr)
AU (1) AU2010321366B2 (fr)
BR (1) BR112012012138B1 (fr)
CA (1) CA2781066C (fr)
DK (1) DK2504331T3 (fr)
ES (1) ES2529105T3 (fr)
IN (1) IN2012DN04868A (fr)
MX (1) MX2012005926A (fr)
MY (1) MY161749A (fr)
NZ (1) NZ600266A (fr)
PL (1) PL2504331T3 (fr)
PT (1) PT2504331E (fr)
RU (1) RU2507203C1 (fr)
WO (1) WO2011060746A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102070618B (zh) * 2009-11-23 2013-08-21 和记黄埔医药（上海）有限公司 一种化合物及其晶体
BR122020023385B1 (pt) * 2014-06-19 2021-05-25 Merial, Inc composições parasiticidas compreendendo derivados de indol, métodos e usos dos mesmos
CN105985326B (zh) * 2015-02-16 2020-04-14 上海宣创生物科技有限公司 嘧啶衍生物晶型ⅲ及其制备方法和用途
WO2016187767A1 (fr) * 2015-05-25 2016-12-01 Hutchison Medipharma Limited Compositions pharmaceutiques et utilisation de celles-ci
JP7308145B2 (ja) * 2016-11-18 2023-07-13 ハッチソン メディファーマ リミテッド 固形腫瘍を治療するための医薬組成物
JP2020164434A (ja) * 2019-03-28 2020-10-08 上野製薬株式会社 ２，６−ナフタレンビス（２−オキサゾリン）の製造方法
WO2021180027A1 (fr) * 2020-03-09 2021-09-16 和记黄埔医药（上海）有限公司 Association pharmaceutique d'anticorps anti-pd-1 et d'inhibiteur de tyrosine kinase multi-récepteurs et sa méthode d'utilisation
EP4324830A1 (fr) * 2021-04-12 2024-02-21 MitoImmune Therapeutics Inc. Nouvelle forme cristalline de 5-[(1,1-dioxido-4-thiomorpholinyl)méthyl]-2-phényl-n-(tétrahydro-2h-pyran-4-yl)-1h-indole-7-amine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090036448A1 (en) * 2004-03-30 2009-02-05 Taisho Pharmecutical Co., Ltd. Pyrimidine derivatives and methods of treatment related to the use thereof
EP1934200A1 (fr) 2005-09-15 2008-06-25 Merck & Co., Inc. Inhibiteurs de la tyrosine kinase
CN101289444B (zh) * 2007-04-16 2012-01-04 和记黄埔医药（上海）有限公司 一种嘧啶衍生物及其医药用途
RU2455994C2 (ru) * 2007-04-16 2012-07-20 Хатчисон Медифарма Энтерпрайзис Лимитед Пиримидиновые производные
TW201008933A (en) * 2008-08-29 2010-03-01 Hutchison Medipharma Entpr Ltd Pyrimidine compounds
CN102070618B (zh) 2009-11-23 2013-08-21 和记黄埔医药（上海）有限公司 一种化合物及其晶体

Also Published As

Publication number Publication date
US8658658B2 (en) 2014-02-25
WO2011060746A1 (fr) 2011-05-26
US20120270889A1 (en) 2012-10-25
CN102070618B (zh) 2013-08-21
CA2781066C (fr) 2014-09-16
AU2010321366B2 (en) 2014-07-24
BR112012012138B1 (pt) 2023-02-07
EP2504331B1 (fr) 2014-11-12
US20140200232A1 (en) 2014-07-17
NZ600266A (en) 2014-06-27
PT2504331E (pt) 2015-02-20
RU2012126112A (ru) 2013-12-27
PL2504331T3 (pl) 2015-04-30
CN102648194B (zh) 2014-10-29
CN102648194A (zh) 2012-08-22
KR20120097526A (ko) 2012-09-04
ES2529105T3 (es) 2015-02-16
EP2504331A1 (fr) 2012-10-03
CN102070618A (zh) 2011-05-25
US8946249B2 (en) 2015-02-03
EP2504331A4 (fr) 2013-04-17
MX2012005926A (es) 2012-11-23
KR101513784B1 (ko) 2015-04-20
AU2010321366A8 (en) 2012-07-05
DK2504331T3 (en) 2014-12-08
BR112012012138A2 (pt) 2017-03-07
JP2013511475A (ja) 2013-04-04
RU2507203C1 (ru) 2014-02-20
MY161749A (en) 2017-05-15
CA2781066A1 (fr) 2011-05-26
AU2010321366A1 (en) 2012-06-14
JP5758399B2 (ja) 2015-08-05

Similar Documents

Publication Publication Date Title
MX336071B (es) Formulaciones intravenosas de antagonistas de neurocinina 1.
IN2012DN04868A (fr)
UA105229C2 (uk) Фармацевтичний склад
MY187718A (en) Pharmaceutical formulations
MY193277A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
MX2013003019A (es) Compuestos de azabenzotiazol, composiciones y metodos de uso.
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
TN2012000248A1 (en) Novel spiropiperidine compounds
EP2590655A4 (fr) Composés et procédés pour l'inhibition du transport de phosphate
IN2012DN03182A (fr)
MX340360B (es) Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas.
WO2010128050A3 (fr) Anti-inflammatoires utilisés comme virostatiques
MX2013010511A (es) Inhibidores triciclicos de girasa.
WO2012015681A3 (fr) Conjugués médicaments-ligands, leur synthèse et intermédiaires correspondants
WO2012135615A3 (fr) Enopeptines, utilisations de celles-ci, et procédés de synthèse de celles-ci
MY160392A (en) Triptolide prodrugs
MX2013011926A (es) Derivados de glicosido y usos de los mismos.
WO2010123545A3 (fr) Inhibiteurs de l'angiogenèse
IN2012DN01292A (fr)
TN2012000105A1 (en) Spirolactam derivatives and uses of same
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
WO2012015687A3 (fr) Conjugués médicament-ligand, leur synthèse et leurs intermédiaires
WO2010146595A3 (fr) Nouveaux polymorphes d'hydrochlorure de flibansérine
GEP20156269B (en) New secondary 8-hydroxyquinoline-7- carboxamide derivatives
WO2011125006A3 (fr) Nouveaux composés sultame